LokomatPro (with Sensation variant)

What it's for

The LokomatPro is a stationary system for robotic gait training in neurological rehabilitation (hospitals). The patient hangs in a harness that takes part of the body weight, and powered orthoses on both sides guide the hips and knees through the rhythm of a walking stride, repeating the same pattern hundreds of times, something no therapist could sustain by hand for half an hour.

The lower-limb drive has adjustable hip and knee angles, and the Sensation variant adds adaptive-intensity algorithms and VR/AR game feedback synchronized with music. The patient is not "doing exercises" but playing a game, which raises motivation for many people. A pediatric version is also available, so the device reaches children with gait disorders too.

The use case is narrow and well defined: neurological rehabilitation in a clinic, not services and not industry. That is the key difference from the mobile exoskeletons described in “Exoskeletons in Rehabilitation and Industry”. Those let a person walk across the floor, whereas here the treadmill with its body-weight support system is part of the device, and the whole unit weighs about a ton. That is why the LokomatPro is equipment for a therapy room, not something you can rent for a weekend. The Swiss manufacturer Hocoma sells it institutionally to clinics and rehabilitation centers.

In the wider picture, it is one of the best-documented medical robots, alongside the surgical systems covered in “da Vinci Robots in Polish Hospitals”.

Who it's for

Yes: for clinics, rehabilitation hospitals and larger neurology centers that run intensive gait therapy and have a qualified team of therapists plus a dedicated room for a device weighing around 1,000 kg. Yes for facilities that value repeatable therapy and documented outcomes; the manufacturer points to 70 clinical studies, including 39 randomized controlled trials (RCTs).

No: for individual patients looking for an exoskeleton for everyday walking at home. Personal designs such as the Ekso Indego Personal or the ReWalk Personal serve that purpose. No for small physiotherapy practices without specialized staff and a budget for installation, servicing and training. No for companies looking for a robot to do work: exoskeletons split into medical and industrial, and the LokomatPro belongs to the first group. Availability in Poland has not been independently confirmed, so check it directly with the manufacturer before buying.

Deployments

Worldwide: more than 1,000 installed units at over 260 facilities by 2020, the most complete confirmation of scale available. The clinical documentation comprises 70 publications, including 39 randomized trials.

In Poland: we have no confirmed deployments on record, and availability in the country has not been independently verified. If you are planning a purchase, ask the manufacturer for a list of reference facilities in your region. Related solutions are mobile clinical and personal exoskeletons such as the EksoNR or the ReWalk Personal, and a broad market overview in “Exoskeletons in Rehabilitation and Industry”.

EksoNR: an FDA-cleared rehabilitation exoskeleton for gait training, sold to clinics with no public price. Instead of a treadmill with body-weight support, the patient walks across the floor with the device, which can feel closer to real life.

Eve: Wandercraft's personal exoskeleton for walking outside the clinic, on commercial sale in the US since September 17, 2026; its price and full specifications are not known. For clinics it signals a new direction, from treadmill therapy to walking in real surroundings.

HAL: the Hybrid Assistive Limb, which works from bioelectric signals in the muscles, available since 2009, mainly through leasing with no retail price list. A different philosophy: the device responds to the patient's intention to move.

Ekso Indego Personal: a home exoskeleton for people with paraplegia, reimbursed by Medicare in the US since 2024; no confirmed price or availability in Poland.

Hocoma was founded in Switzerland in 1999 and has built a portfolio of rehabilitation robotics from the start. The Lokomat became its flagship product: by 2020, more than a thousand units had been installed at over 260 facilities worldwide.

Successive versions added features: a pediatric variant and Sensation, with adaptive-intensity algorithms and VR/AR games. Around the Lokomat, the manufacturer has built a whole family of devices: Erigo for early mobilization and Andago for mobile gait training. This lets a patient move through the successive stages of therapy on equipment from the same supplier. We do not have exact launch dates for the individual versions, so we do not give any.